A2B adenosine receptor antagonists and their potential indications

Author： Zablocki Jeff   Elzein Elfatih   Kalla Rao  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.16, Iss.10, 2006-10, pp. : 1347-1357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A2B Adenosine Receptor Antagonists: Recent Developments

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 12, 2005-12 ,pp. : 1053-1060

Bentham Science Publishers

Access to resources Recommend Favorite

Potential of Adenosine A Receptor Antagonists in the Treatment of Movement Disorders

By Mally J.  

CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 311-320

Adis International

Access to resources Recommend Favorite

Towards Next Generation Adenosine A2A Receptor Antagonists

By  

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-01 ,pp. : 3918-3935

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine A2A Receptor Antagonists for Parkinson’s Disease: Rationale, Therapeutic Potential and Clinical Experience

By Hauser Robert A.  

Drugs & Aging, Vol. 22, Iss. 6, 2005-01 ,pp. : 471-482

Adis International

Access to resources Recommend Favorite

A1-Adenosine receptor antagonists

By Müller C.E.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 5, 1997-05 ,pp. : 419-440

Informa Healthcare

Access to resources Recommend Favorite